Grand Pharmaceutical (00512.HK): GPN01768 [TP-03, (Loteranal Eye Drops) 0.25%), a globally innovative ophthalmic drug introduced by the Group for the treatment of Demodex blepharitis, recently officially obtained a drug registration certificate issue

2026-03-22

Grand Pharmaceutical (00512.HK): GPN01768 [TP-03, (Loteranal Eye Drops) 0.25%), a globally innovative ophthalmic drug introduced by the Group for the treatment of Demodex blepharitis, recently officially obtained a drug registration certificate issued by the National Medical Products Administration of the People's Republic of China. Moreover, no supplementary information was requested during the drug review process, achieving "zero supplementary information" approval for market launch.

Other News
2026-03-22

Domestic News 1. He Lifeng meets with multinational corporation executives. 2. Several paper companies issue price increase notices for April. 3. Prices of gold jewelry from several brands fall below 1400 yuan/gram. 4. Huawei launches its new gen

2026-03-22

A spokesperson for the Saudi Ministry of Defense said: Three ballistic missiles were detected being launched toward the Riyadh area. One of them was intercepted, and the other two landed in uninhabited areas.